Interview with the CEO of TiGenix, maker of the cell-based cartilage repair product ChrondroCelect

Interview with Eduardo Bravo, CEO, TiGenix - Belgium (PharmaBoardRoom) Mr Bravo, in relation to your previous career in big pharma companies, you have recently made a shift into much smaller entities including Cellerix and TiGenix. What motivated you to make such a dramatic and bold shift in your professional life? I was young and ambitious and despite having a successful career in the big pharmaceutical industry, I opted for a more entrepreneurial path where I could contribute to building something from scratch. Before doing so, I met with Cristina Garmendia (she has recently served as the Mi...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top